2019
DOI: 10.1007/s40944-018-0247-0
|View full text |Cite
|
Sign up to set email alerts
|

Uterine Sarcomas: Surgical Management, Adjuvant Therapy and Survival Outcome. Experience at Gujarat Cancer and Research Institute

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…Surgical intervention is the treatment of choice with Total abdominal hysterectomy, bilateral salpingo -oophorectomy for postmenopausal females and those with metastatic disease and Total abdominal hysterectomy without bilateral salphingo -oophorectomy for premenopausal females. 5 Hormonal therapy may be an option in hormone receptor positive tumors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Surgical intervention is the treatment of choice with Total abdominal hysterectomy, bilateral salpingo -oophorectomy for postmenopausal females and those with metastatic disease and Total abdominal hysterectomy without bilateral salphingo -oophorectomy for premenopausal females. 5 Hormonal therapy may be an option in hormone receptor positive tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Whereas cellular leiomyomas and leiomyosarcomas are usually positive for CD10 and positive for desmin, immunohistochemistry can be helpful in difficult cases. 4,5 Carcinosarcoma was also a differential diagnosis as they commonly present as a uterine polyp in post menopausal women. But in our case, there was absence features of endometrioid, serous or clear cell type adenocarcinoma.…”
Section: The Ihc Profile Of This Casementioning
confidence: 99%
“…Approximately 1 in every 800 women believed to have a leiomyoma actually has a sarcoma 6,7. Though uterine sarcoma is very rare, it usually causes poor prognosis 8. However, preoperative examination, either imaging with ultrasonography or with positron emission tomography scans, is not capable to differentiate benign from malignant smooth muscle masses.…”
Section: Introductionmentioning
confidence: 99%